Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Laterza, RM; De Gennaro, M; Tubaro, A et al.
Female pelvic congenital malformations. Part I: embryology, anatomy and surgical treatmentEUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. Bd. 159. H. 1. 2011 S. 26-34
Foerster, F; Aktas, B; Geberth, M et al.
First-Line Bevacizumab (Bev) Combined With Paclitaxel (pac) In Older Patients (pts) Treated for HER2-Negative Metastatic Breast Cancer (mBC) in a Routine Oncology Practice StudyEUROPEAN JOURNAL OF CANCER. Bd. 47. 2011 S. S351-S352
Karn, T; Ruckhaberle, E; Hanker, L et al.
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistanceBREAST CANCER RESEARCH AND TREATMENT. Bd. 130. H. 2. 2011 S. 409-420
Karn, T; Pusztai, L; Holtrich, U et al.
Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive SignaturesPLOS ONE. Bd. 6. H. 12. 2011 S. -
Hohmann, M
Hypotonie, orthostatische Hypotonie und V.-Cava-KompressionssyndromWerner Rath, Ulrich Gembruch, Stephan Schmidt (Hrsg). Geburtshilfe und Perinatalmedizin. 2. Aufl. Stuttgart: Georg Thieme Verlag 2011
Albrich, S; Laterza, R; Skala, C et al.
Impact of mode of delivery on levator morphology: a prospective observational study with three-dimensional ultrasound early in the postpartum periodBJOG. 2011 S. 1-9
Skala, CE; Renezeder, K; Albrich, S et al.
Mesh complications following prolapse surgery: management and outcomeEUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. Bd. 159. H. 2. 2011 S. 453-456
Kantelhardt, EJ; Vetter, M; Spinda, K et al.
Molecular types, uPA/PAI-1, clinical and pathological features in node-negative breast cancer: Distribution within the clinical trial NNBC 3-Europe compared to a single-institution cohortBREAST. Bd. 20. 2011 S. S38-S38
Schrutka, L; Laterza, R; Albrich, S et al.
Pelvic Floor Dysfunction after levator trauma 1 year after delivery. A prospective case-control studyInt Urogynecol J. Bd. 22. H. S1. 2011 S. Abs 124
Untch, M; Fasching, PA; Konecny, GE et al.
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-results at the time of surgeryANNALS OF ONCOLOGY. Bd. 22. H. 9. 2011 S. 1988-1998